Jean has 30 years’ experience as a statistician in the pharmaceutical industry, covering all phases of drug development, several therapeutic areas and work in global pharmaceutical companies as well as CROs.
Jean has acted as statistical representative at many regulatory meetings at various stages of drug development, including an FDA Advisory Committee and a CHMP Oral Explanation. She has experience of working in both the US and UK and has worked closely with teams in Japan and China.
Jean has a particular interest in analysis issues around missing data and the development of estimands as outlined in the proposed ICH-E9 addendum. She has experience of applying Bayesian techniques in study design, including facilitation of prior elicitation sessions with clinical experts.
Jean has an MSc in Statistics and Operational Research (Birkbeck College, University of London, 1991), a postgraduate Diploma in Statistics (University College London, 1988) and a BSc in Mathematics/Statistics (Leeds University, 1987).